BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
BioCardia, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.90−0.02 (-2.46%)
Close on Oct 19, 2026
- Market cap
- $10.85M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 30, 2024 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Aug 14, 2019(first seen in filings) | 1-for-9 reverse | Earlier per-share figures multiplied by 9 |
| Jun 6, 2019 | 1-for-9 reverse | Earlier per-share figures multiplied by 9 |
| Nov 3, 2017 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Mar 30, 2017(first seen in filings) | 1-for-12.33 reverse | Earlier per-share figures multiplied by 12.3333 |
| Mar 14, 2008 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jan 6, 2004 | 6-for-1 | Earlier per-share figures divided by 6 |
| Aug 23, 2001 | 1-for-3 reverse | Earlier per-share figures multiplied by 3 |